Edition:
United Kingdom

Camurus AB (CAMX.ST)

CAMX.ST on Stockholm Stock Exchange

100.40SEK
23 May 2018
Change (% chg)

-1.40kr (-1.38%)
Prev Close
101.80kr
Open
102.80kr
Day's High
102.80kr
Day's Low
100.00kr
Volume
10,216
Avg. Vol
37,678
52-wk High
147.80kr
52-wk Low
91.30kr

Chart for

About

Camurus AB is a Sweden-based research and development based pharmaceutical company with a focus on the development and commercialization of specialty medicines, providing patients suffering from serious and chronic disease, such as opioid dependence, pain, cancer, acromegaly, and neuroendocrine tumors. The Company has a... (more)

Overall

Beta: --
Market Cap(Mil.): kr4,585.62
Shares Outstanding(Mil.): 37.28
Dividend: --
Yield (%): --

Financials

  CAMX.ST Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -3.41 -- --
ROI: -23.26 14.84 14.38
ROE: -23.26 16.34 16.07

BRIEF-Camurus Q4 Operating Loss Widens To SEK ‍66.1​ Million

* Q4 NET SALES SEK ‍5.5​ MILLION VERSUS SEK 37.1 MILLION YEAR AGO

15 Feb 2018

BRIEF-Camurus AB Q4 Net Revenue Sek 5.5 Million Versus Sek 37.1 Million Year Ago

* Q4 NET REVENUE SEK 5.5 MILLION VERSUS SEK 37.1 MILLION YEAR AGO

15 Feb 2018

Earnings vs. Estimates